Problems and approaches in investigating the role of micronutrients in the aetiology of cancer in humans

British Medical Bulletin

Volumn 55, Issue 3, 1999, Pages 600-618

  Little, Julian ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRACE ELEMENT;

CANCER; CANCER PREVENTION; CANCER RISK; ENVIRONMENTAL FACTOR; FOOD INTAKE; FRUIT; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; REVIEW; VEGETABLE;

EID: 0032731828     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902493     Document Type: Review

References (141)

1. Pisani P, Parkin DM, Muñoz N et al. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol, Biomarkers Prev 1997; 6: 387-400
2. Parkin DM, Stjernswärd J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163-82
3. Boyle P, La Vecchia C, Maisonneuve P et al. Cancer epidemiology and prevention. In: Peckham M, Pinedo HM, Veronesi U (Eds) Oxford Textbook of Oncology, Vol 1, Oxford: Oxford University Press, 1995; 199-273
4. Doll R, Peto R. The Causes of Cancer. Oxford: Oxford University Press, 1981
5. Harvard Report on Cancer Prevention. Causes of human cancer. Cancer Causes Control 1996; 7: S1-58
6. World Cancer Research Fund in Association with American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a global perspective. Menasha: American Institute for Cancer Research, 1997
7. Willett WC. Total energy intake and nutrient composition: dietary recommendations for epidemiologists. Int J Cancer 1990; 46: 770-1
8. Margetts BM, Nelson M (Eds) Design Concepts in Nutritional Epidemiology. Oxford: Oxford University Press, 1991
9. Riboli E, Slimani N, Kaaks R. Identifiability of food components for cancer chemoprevention. In: Stewart BW, McGregor D, Kleihues P (Eds) Principles of Chemoprevention, IARC Scientific Publications No. 139. Lyon: IARC, 1996
10. Blomhoff R, Green MH, Berg T et al. Transport and storage of vitamin A. Science 1990; 250: 399-404
11. Hunter D. Biochemical indicators of dietary intake. In: Willett W (Ed) Nutritional Epidemiology, New York: Oxford University Press, 1990: 143-216
12. Buiatti E, Balzi D, Barchielli A. Intervention trials for cancer prevention, IARC Technical Report No. 18. Lyon: IARC, 1994
13. Kelloff GJ, Crowell JA, Boone CW et al. Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute. J Cell Biochem Suppl 1994; 20: 55-62
14. Hakama M, Beral V, Buiatti E, Faivre J, Parkin DM (Eds) Chemoprevention in Cancer Control. Lyon: IARC, 1996.
15. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35
16. Omenn GS, Goodman GE, Thornquist MD et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-9
17. Greenberg ER, Baron JA, Stukel TA et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 1990; 323: 789-95
18. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9
19. Greenberg ER, Baron JA, Tosteson TD et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141-7
20. MacLennan R, Macrae F, Bain C et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst 1995; 87: 1760-6
21. Huttunen JK. Why did antioxidants not protect against lung cancer in the Alpha-Tocopherol Beta-Carotene cancer prevention study? In: Hakama M, Beral V, Buiatti E et al (Eds) Chemoprevention in Cancer Control, IARC Scientific Publications No. 136. Lyon: IARC, 1996: 63-5
22. IARC Working Group. IARC Handbooks of Cancer Prevention, Vol 2: Carotenoids. Lyon: IARC, 1998
23. Blot WJ, Li JY, Taylor PR et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-92
24. Gaziano JM, Manson JE, Ridker PM et al. Beta-carotene therapy for chronic stable angina. Circulation 1990; 82: III-201
25. Gaziano JM, Manson JE, Ridker PM et al. Beta-carotene therapy for chronic stable angina. Circulation 1996; 94: I-508
26. Omenn GS. Micronutrients (vitamins and minerals) as cancer-preventive agents. In: Stewart BW, McGregor D, Kleihues P (Eds) Principles of Chemoprevention, IARC Scientific Publications No. 139. Lyon: International Agency for Research on Cancer, 1996: 33-45
27. Buiatti E. Evaluation of human trial design. In: Stewart BW, McGregor D, Kleihues P, eds. Principles of Chemoprevention, IARC Scientific Publications No. 139. Lyon: IARC, 1996: 201-69
28. Gaziano JM, Hennekens CH, Buring JE. Methodological issues in the design of primary prevention trials. In: Hakama M, Beral V, Buiatti E et al (Eds) Chemoprevention in Cancer Control, IARC Scientific Publication No. 136. Lyon: IARC, 1996: 7-12
29. Beral V, Costa A, Kroes R et al. Conclusions and recommendations. In: Hakama M, Beral V, Buiatti E et al (Eds) Cbemoprevention in Cancer Control, IARC Scientific Publication No. 136. Lyon: IARC, 1996: 139-40
30. Conti CJ, Gimenez-Conti IB. Molecular genetic alterations as intermediate end points in Chemoprevention studies. In: Stewart BW, McGregor D, Kleihues P (Eds) Principles of Chemoprevention, IARC Scientific Publication No. 139. Lyon: IARC, 1996: 249-60
31. Taubes G. Epidemiology faces its limits. Science 1995; 269: 164-9
32. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300
33. Elwood JM. Causal relationships in medicine. A practical system for critical appraisal. Oxford: Oxford University Press, 1988
34. IARC Working Group. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC, 1994
35. Willett W, Greenland S, MacMahon B et al. The discipline of epidemiology. Science 1995; 269: 1325-6
36. Beems RB. The effect of beta-carotene on BP-induced respiratory tract tumors in hamsters. Nutr Cancer 1987; 10: 197-204
37. Wolterbeek APM, Schoevers EJ, Bruyntjes JP et al. Benzo[a]-pyrene-induced respiratory tract cancer in hamsters fed in diet rich in beta-carotene. A histomorphological study. J Environ Pathol Toxicol Oncol 1995; 14: 35-43
38. Neben DW. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 1997; 60: 265-71
39. Leakey RE. The Making of Mankind. London: Michael Joseph Limited, 1981
40. Ames BN. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 1983; 221: 1256-64
41. Cerutti PA. Prooxidant states and tumour promotion. Science 1985; 227: 375-81
42. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14
43. Weinberg ED. Association of iron with colorectal cancer. Biometals 1994; 7: 211-6
44. Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990; 8: 191-200
45. Stevens RG, Jones DY, Micozzi MS et al. Body iron stores and the risk of cancer. N Engl J Med 1988; 319: 1047-52
46. Knekt P, Reunanen A, Takkunen H et al. Body iron stores and risk of cancer. Int J Cancer 1994; 56: 379-382
47. Wurzelmann JI, Silver A, Schreinemachers DM et al. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 503-7
48. Freudenheim JL, Graham S, Marshall JR et al. A case-control study of diet and rectal cancer in Western New York. Am J Epidemiol 1990; 131: 612-24
49. Tuyns AJ, Haelterman M, Kaaks R. Colorectal cancer and the intake of nutrients: oligosaccharides are a risk factor, fats are not. A case-control study in Belgium. Nutr Cancer 1987; 10: 181-96
50. Peters RK, Pike MC, Garabrant D et al. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992; 3: 457-73
51. Nelson RL, Davis FG, Sutter E et al. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 1994; 86: 455-60
52. Hoff G, Moen IE, Trygg K et al. Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors. Scand J Gastroenterol 1986; 21: 199-204
53. Macquart-Moulin G, Riboli E, Cornée J et al. Colorectal polyps and diet: a case-control study in Marseilles. Int J Cancer 1987; 40: 179-88
54. Little J, Logan RFA, Hawtin PG et al. Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer 1993; 67: 177-84
55. Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994; 45: 146-9
56. Nelson RL, Davis FG, Persky V et al. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995; 76: 875-9
57. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-91
58. Goelz SE, Vogelstein B, Hamilton SR et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228: 187-90
59. Kune GA, Vitetta L. Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer 1992; 18: 97-111
60. Giovannucci E, Stampfer MJ, Colditz GA et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875-84
61. Herbert V. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 1987; 45: 661-70
62. Benito E, Stiggelbout A, Bosch FX et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 1991; 49: 161-7
63. Freudenheim JL, Graham S, Marshall JR et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991; 20: 368-74
64. Meyer F, White E. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 1993; 138: 225-36
65. Ferraroni M, La Vecchia C, D'Avanzo B et al. Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 1994; 70: 1150-5
66. Giovannucci E, Rimm EB, Ascherio A et al. Alcohol, low-methionine - low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995; 87: 265-73
67. Glynn SA, Albanes D, Pietinen P et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996; 5: 487-94
68. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 769-74
69. Giovannucci E, Stampfer MJ, Colditz GA et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129: 517-24
70. Benito E, Cabeza E, Moreno V et al. Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer 1993; 55: 213-9
71. Bird CL, Swendseid ME, Witte JS et al. Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1995; 4: 709-14
72. Tseng M, Murray SC, Kupper LL et al. Micronutrients and risk of colorectal adenomas. Am J Epidemiol 1995; 141: S71
73. Baron JA, Sandler RS, Haile RW et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998; 90: 57-62.
74. Boutron-Ruault MC, Senesse P, Faivre J et al. Folate and alcohol intakes: related or independent roles in the adenoma-carcinoma sequence? Nutr Cancer 1996; 26: 337-46
75. La Vecchia C, Braga C, Negri E et al. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 1997; 73: 525-30
76. Slattery ML, Caan BJ, Potter JD et al. Dietary energy sources and colon cancer risk. Am J Epidemiol 1997; 145: 199-210
77. Paspatis GA, Kalafatis E, Oros L et al. Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis Colon Rectum 1995; 38: 64-8
78. Paspatis G, Xourgias B, Mylonakou E et al. A prospective clinical trial to determine the influence of folate supplementation on the formation of recurrent colonic adenomas. Gastroenterology 1994; 106: A425
79. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3
80. van der Put NMJ, Gabreëls F, Stevens EMB et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-51
81. Chen J, Giovannucci E, Kelsy K et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862-4
82. Ma J, Stampfer MJ, Giovannucci E et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102
83. Ward A, Summers MJ, Sim E. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 1995; 49: 1759-67
84. Bell DA, Badawi AF, Lang NP et al. Polymorphism in the N-Acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995; 55: 5226-9
85. Hickman D, Pope J, Patil SD et al. Expression of arylamine N-acetyltransferase in human intestine. Gut 1998; 42: 402-9
86. Bell DA, Stephens EA, Castranio T et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995; 55: 3537-42
87. Jenkins M, Bigler J, Kampman E et al. Associations between colon cancer and acetylation (NAT1 and NAT2) genotypes in a large population-based study. Am J Epidemiol 1997; 145: S68
88. Chen J, Stampfer MJ, Hough HL et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998; 58: 3307-11
89. Probst-Hensch NM, Haile RW, Li DS et al. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 1996; 17: 2125-9
90. Meenan J, O'Hallinan E, Lynch S et al. Folate status of gastrointestinal epithelial cells is not predicted by serum and red cell folate values in replete subjects. Gut 1996; 38: 410-3
91. Meenan J, O'Hallinan E, Scott J et al. Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterology 1997; 112: 1163-8
92. Kim YI, Fawaz K, Knox T et al. Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps. Am J Clin Nutr 1998; 68: 866-72
93. Jacob RA, Gretz DM, Taylor PC et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998; 128: 1204-12
94. Cravo M, Fidalgo P, Pereira AD et al. Folate supplementation increases the degree of DNA methylation in patients with colonic neoplasms. Gastroenterology 1993; 104: A394
95. Blount BC, Ames BN. DNA damage in folate deficiency. Baillières Clin Haematol 1995; 8: 461-78
96. Branda RF, Blickensdorfer DB. Folate deficiency increases genetic damage caused by alkylating agents and gamma-irradiation in Chinese hamster ovary cells. Cancer Res 1993; 53: 5401-8
97. Bunin GR, Kuijten RR, Buckley JD et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993; 329: 536-41
98. Bunin GR, Kuijten RR, Boesel CP et al. Maternal diet and risk of astrocytic glioma in children: a report from the Children's Cancer Group (United States and Canada). Cancer Causes Control 1994; 5: 177-87
99. Preston-Martin S, Pogoda JM, Mueller BA et al. Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation. Environ Health Perspect 1998; 106: 887-92
100. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7
101. Little J. Is folic acid pluripotent? A review of the associations with congenital anomalies, cancer and other diseases. In: Ioannides C, Lewis DFV (Eds) Drugs, Diet and Disease. Vol 1. Mechanistic Approaches to Cancer. New York: Ellis Horwood, 1995; 259-308
102. van der Put NMJ, Steegers-Theunissen RPM, Frosst P et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1
103. Whitehead AS, Gallagher P, Mills JL et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-6
104. Bjørke-Monsen AL, Ueland PM, Schneede J et al. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. Q J Med 1997; 90: 593-6
105. Mornet E, Muller F, Lenvoisé-Furet A et al. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 1997; 100: 512-4
106. Narod SA, Hawkins MM, Robertson CM et al. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997; 60: 474-85
107. Little J. Childhood cancer and neural tube defects. Am J Hum Genet 1997; 61: 1204-5
108. Foreman NK, Pearson AD. Maternal diet and primitive neuroectodermal brain tumors in children. N Engl J Med 1993; 329: 1963
109. Thorne RN, Pearson ADJ, Nicoll JAR et al. Decline in incidence of medulloblastoma in children. Cancer 1994; 74: 3240-4
110. Elwood JM, Elwood JH, Little J. Diet. In: Elwood JM, Little J, Elwood JH (Eds) Epidemiology and Control of Neural Tube Defects, Oxford: Oxford University Press, 1992: 521-603
111. Garland CF, Goreham ED, Garland FC. Re: 'physical activity, diet, and risk of colon cancer in Utah'. Am J Epidemiol 1990; 131: 568-9
112. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990; 19: 820-1
113. Eisman JA, Martin TJ, MacIntyre I et al. 1,25-dihydroxyvitamin-D receptor in breast cancer cells. Lancet 1979; 2: 1335-6
114. Morrison NA, Yeoman R, Kelly PJ et al. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-9
115. Ingles SA, Haile RW, Henderson BE et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997; 6: 93-8
116. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7
117. Taylor JA, Hirvonen A, Watson M et al. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996; 56: 4108-10
118. Ingles SA, Haile RW, Henderson B et al. Loci in the 5′ and 3′ regions of the vitamin D receptor gene interact to influence breast cancer risk. Am J Hum Genet 1997; 61: A201
119. Yamagata Z, Zhang Y, Asaka A et al. Association of breast cancer with vitamin D receptor gene polymorphism. Am J Hum Genet 1997; 61: A388
120. Zhang Y, Kiel DP, Kreger BE et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997; 336: 611-7
121. Riggs BL. Vitamin D-receptor genotypes and bone density. N Engl J Med 1997; 337: 125-6
122. Sainz J, Van Tornout JM, Laro ML, et al. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 1997; 337: 77-82
123. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10: 1307-12
124. Feldman D. Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk. J Natl Cancer Inst 1997; 89: 109-11
125. Corder EH, Guess HA, Hulka BS et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993; 2: 467-72
126. Braun MM, Helzsover KJ, Hollis BW et al. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995; 6: 235-9
127. Gann PH, Ma J, Hennekens CH et al. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 121-6
128. Nomura AMY, Stemmermann GN, Lee J et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 1998; 9: 425-32
129. Ingles SA, Ross RK, Yu MC et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166-70
130. 3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res 1987; 7: 817-21
131. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993; 53: 3712-8
132. 3 are differentially modified by 9-cis-retinoic acid. Cancer Res 1996; 56: 623-32
133. Li F. Familial aggregation. In: Schottenfeld D, Fraumeni Jr JF (Eds) Cancer Epidemiology and Prevention, New York: Oxford University Press, 1996: 546-58
134. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 1988; 127: 674-83
135. Khoury MJ, Stewart W, Beaty TH. The effect of genetic susceptibility on causal inference in epidemiologic studies. Am J Epidemiol 1987; 126: 561-7
136. Brown PO, Hartwell L. Genomics and human disease - variations on variation. Nat Genet 1998; 18: 91-3
137. Hwang SJ, Beaty TH, Liang KY et al. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol 1994; 140: 1029-37
138. Schaid DJ, Sommer SS. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 1994; 55: 402-9
139. Umbach DM, Weinberg CR. Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat Med 1997; 16: 1731-43
140. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. Design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10
141. Giovannucci E, Rimm EB, Wolk A et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998; 58: 442-7